ITEM 2.03 | CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT. |
Senior Secured Note Issuance
As previously reported, on March 29, 2023, Oncor entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with the purchasers named therein, which provided for the issuance by Oncor of certain senior secured notes. Pursuant to the Note Purchase Agreement, on March 29, 2023, Oncor sold $200,000,000 aggregate principal amount of 5.50% Senior Secured Notes, Series C, due May 1, 2026 (the “Series C Notes”), $72,000,000 aggregate principal amount of 5.34% Senior Secured Notes, Series D, due May 1, 2031 (the “Series D Notes”) and $80,000,000 aggregate principal amount of 5.45% Senior Secured Notes, Series E, due May 1, 2036 (the “Series E Notes” and, together with the Series C Notes and the Series D Notes, the “March Issuance Notes”).
On April 26, 2023, pursuant to the Note Purchase Agreement, Oncor sold an additional $28,000,000 aggregate principal amount of 5.34% Senior Secured Notes, Series D, due May 1, 2031 (the “Additional Series D Notes”) and an additional $20,000,000 5.45% Senior Secured Notes, Series E, due May 1, 2036 (the “Additional Series E Notes” and together with the Additional Series D Notes, the “April Issuance Notes”).
Oncor used the proceeds from the sale of the April Issuance Notes for general corporate purposes.
The Additional Series D Notes bear interest at a rate of 5.34% per annum and mature on May 1, 2031. The Additional Series E Notes bear interest at a rate of 5.45% per annum and mature on May 1, 2036. Interest on the Additional Series D Notes and the Additional Series E Notes will accrue from April 26, 2023 and will be payable semi-annually on May 1 and November 1 of each year, beginning on November 1, 2023.
The Additional Series D Notes and the Additional Series E Notes have the same terms as the Series D Notes and the Series E Notes, respectively, except that initial interest will begin to accrue on them from the date of their issuance in April. The Additional Series D Notes and the Additional Series E Notes are part of the same series as the Series D Notes and the Series E Notes, respectively.
The March Issuance Notes and the April Issuance Notes were sold under Section 4(a)(2) of the Securities Act of 1933, as amended. This current report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the March Issuance Notes or the April Issuance Notes.
Additional details regarding the Notes Purchase Agreement, the March Issuance Notes and the April Issuance Notes are contained in Item 1.01 and Item 2.03 of Oncor’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 29, 2023 (“Prior 8-K”) and are incorporated herein by reference. The foregoing discussion of the terms of the Note Purchase Agreement is not complete and is subject to, and qualified in its entirety by reference to, the Note Purchase Agreement filed as Exhibit 10.1 to the Prior 8-K.
AR Facility
The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.